Integrated safety analysis of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with ovarian cancer in the treatment and maintenance settings Meeting Abstract
| Authors: | Kristeleit, R. S.; Oza, A. M.; Oaknin, A.; Aghajanian, C.; Tinker, A. V.; Tredan, O.; O'Malley, D. M.; Leary, A.; Konecny, G. E.; Lorusso, D.; Weberpals, J. I.; Goble, S.; Maloney, L.; Cameron, T.; Swisher, E.; McNeish, I. A.; Shapira-Frommer, R.; Ledermann, J. A.; Coleman, R. L. |
| Abstract Title: | Integrated safety analysis of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with ovarian cancer in the treatment and maintenance settings |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz250.010 |
| Language: | English |
| ACCESSION: | WOS:000491295503051 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz250.010 |
| Notes: | Meeting Abstract: 1002P -- Appears on pages v409-v410 of the abstract book -- Source: Wos |
